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EMT (10, (12) (13) (14) . To date, however, there has been no comprehensive analysis of the pattern of soluble factors released by tumor cells undergoing a switch from an epithelial to a mesenchymal-like phenotype along the course of carcinoma progression. The characterization of the "secretory phenotype" of tumor cells undergoing EMT might help to understand the potential impact that this phenotypic switch could have on the remodeling of the tumor microenvironment, therefore favoring tumor progression.
In a previous study, we have demonstrated the role of the T-box transcription factor Brachyury in the induction of EMT and metastatic potential in various human cancer cell lines (15) . We have also demonstrated that Brachyury mRNA expression is 
Materials and Methods

Cell Culture
The human carcinoma cell lines used in this study, luminal breast MCF7, T47D, and BT474; basal breast MDA-MD-231 and MDA-MB-436; pancreatic PANC-1, and the lung cancer cell line H460 were obtained from the American Type Culture Collection (ATCC, Gaithersburg, MD) and propagated in RPMI 1640 medium with 2mM glutamine, 1X solution of penicillin/streptomycin (Mediatech, Inc., Herndon, VA) and 10% fetal bovine serum (Gibco, Invitrogen, Carlsbad, CA). MCF7 and PANC-1 cells were stably transfected with a control pcDNA4/TO or a vector encoding for the full length human Brachyury protein (pBrachyury); the lung H460 and the breast MDA-MB-436 tumor cells were stably transfected with a control or a shRNA specific for Brachyury, as previously described (15) .
Cytokine and chemokine array
The level of secreted cytokines and chemokines was analyzed in the supernatants of MCF7 and PANC-1 tumor cell pairs by using a protein cytokine array for 79 human cytokines (RayBio Human G Series Array V, RayBiotech, Inc., Norcross GA). Cells were plated in serum free RPMI 1640 medium (Mediatech, Inc.) for 24 hours; supernatants were collected and analyzed following the manufacturer's recommendations. Cytokine and chemokine levels in each membrane were normalized by comparison to the intensity of positive control spots.
Research. (-ΔCt) .
IL-8 ELISA
IL-8 in 100 μl of serum-free supernatants from tumor cell pairs was measured using a human IL-8 ELISA Kit (RayBiotech, Inc.), as directed by the manufacturer.
Promoter assay
Tumor cells were transfected with 50 ng of a Brachyury promoter-or a control promoterluciferase vector (SwitchGear Genomics, Menlo Park, CA) using Fugene-6 (Roche, San Francisco, CA), and subsequently treated with recombinant IL-8 in triplicate wells.
Forty-eight hours later, tumor cells were incubated with 100 μl of ONE-Glo Luciferase substrate (Promega, Madison, WI) and Luciferase activity was measured using a 1450
Betaplate reader (Perkin-Elmer, Waltham, MA).
Immunofluorescence
Immunofluorescent analysis of tumor cells cultured on glass cover slips was performed as previously described (15) . For inhibition of IL-8 signaling, cells were cultured for 72 hours in medium containing 1μg/ml of blocking antibodies specific for the IL-8 receptors or a neutralizing IL-8 antibody (clone 6217, R&D Systems, Minneapolis, MN).
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Migration and invasion assays
Invasion assay was performed as previously described (15) 
Statistical methods
Data were analyzed using GraphPad Prism (version 4) (GraphPad Software, La Jolla, CA). Data points in graphs represent the mean ± SEM and p< 0.05 is considered significant.
Results
Secretory phenotype of epithelial tumor cells undergoing Brachyury-induced EMT
To investigate whether overexpression of Brachyury could modulate the pattern of soluble mediators secreted by epithelial tumor cells, we analyzed by using protein arrays the levels of multiple cytokines, chemokines, and growth factors released by the human breast MCF7 and pancreatic PANC-1 carcinoma cells that were transfected with an empty vector (pcDNA) versus a vector encoding for human Brachyury (pBrachyury) (Fig. 1A and B) . Serum-free conditioned media (CM) was obtained from cell-normalized cultures of each cell line; as shown in Figure 1C 
IL-8 treatment of tumor cells results in the enhanced transcriptional activity of the
Brachyury promoter in MCF7 cells (Fig. 6C) .
Brachyury is essential for the induction of invasiveness and Fibronectin expression mediated by IL-8
Treatment of MCF7 cells with recombinant IL-8 significantly improved their ability to invade the extracellular matrix in vitro (Fig. 7A) . IL-8 was also able to enhance the invasive abilities of the MDA-MB-231 and MDA-MB-436 tumor cells, which naturally exhibit higher invasive capacity than MCF7 cells (Fig. 7A) . To investigate 
The development of strategies aimed at interfering with cytokine and growth factor regulatory loops appears then as a rational approach for improving therapeutic efficacy against tumor progression. In particular, from our results, blockade of the IL-8/IL-8R axis seems an attractive strategy that could result in the reversion of the metastatic phenotype 
